Copaxone and Acute myocardial infarction - a phase IV clinical study of FDA data
Acute myocardial infarction is found among people who take Copaxone, especially for people who are male, 40-49 old, have been taking the drug for 5 - 10 years.
The phase IV clinical study analyzes which people take Copaxone and have Acute myocardial infarction. It is created by eHealthMe based on reports of 53,633 people who have side effects when taking Copaxone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available for the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,633 people reported to have side effects when taking Copaxone.
Among them, 22 people (0.04%) have Acute myocardial infarction.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 52,184 Copaxone users for its effectiveness, alternative drugs and more.
What is Acute myocardial infarction?
Acute myocardial infarction (acute heart attack) is found to be associated with 2,063 drugs and 1,439 conditions by eHealthMe.
Number of Copaxone and Acute myocardial infarction reports submitted per year:
Time on Copaxone when people have Acute myocardial infarction *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 33.33 %
- 10+ years: 0.0 %
Gender of people who have Acute myocardial infarction when taking Copaxone *:
- female: 22.73 %
- male: 77.27 %
Age of people who have Acute myocardial infarction when taking Copaxone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 5 %
- 40-49: 60 %
- 50-59: 10 %
- 60+: 25 %
Common drugs people take besides Copaxone *:
- Vioxx: 11 people, 50.00%
- Effexor: 11 people, 50.00%
- Omeprazole: 3 people, 13.64%
- Allopurinol: 1 person, 4.55%
- Avandia: 1 person, 4.55%
- Avonex: 1 person, 4.55%
- Baclofen: 1 person, 4.55%
- Carbamazepine: 1 person, 4.55%
- Diovan: 1 person, 4.55%
- Fluoxetine: 1 person, 4.55%
Common side effects people have besides Acute myocardial infarction *:
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 11 people, 50.00%
- Stable Angina (a constant chest pain): 11 people, 50.00%
- Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 11 people, 50.00%
- Cellulitis (infection under the skin): 11 people, 50.00%
- Hyperlipidaemia (presence of excess lipids in the blood): 11 people, 50.00%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 11 people, 50.00%
- Ventricular Fibrillation (abnormally irregular heart rhythm): 11 people, 50.00%
- Gastric Ulcer (stomach ulcer): 9 people, 40.91%
- Dizziness: 9 people, 40.91%
- Acute Respiratory Failure: 9 people, 40.91%
Common conditions people have *:
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 9 people, 40.91%
- Type 2 Diabetes: 1 person, 4.55%
- Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 1 person, 4.55%
- Nuclear Magnetic Resonance Imaging Brain: 1 person, 4.55%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 4.55%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 4.55%
- Essential Hypertension (primary hypertension): 1 person, 4.55%
- Diabetes: 1 person, 4.55%
* Approximation only. Some reports may have incomplete information.
Do you take Copaxone and have Acute myocardial infarction?Check whether Acute myocardial infarction is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
How severe was Acute myocardial infarction and when was it recovered:
Expand to all the drugs that have ingredients of glatiramer acetate:
Alternative drugs to, pros and cons of Copaxone:
- Copaxone (52,184 reports)
Common Copaxone side effects:
Browse all side effects of Copaxone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Acute myocardial infarction treatments and more:
- Acute myocardial infarction (39,756 reports)
COVID vaccines that are related to Acute myocardial infarction:
- Acute myocardial infarction in Moderna COVID Vaccine
- Acute myocardial infarction in Pfizer BioNTech Covid Vaccine
- Acute myocardial infarction in Johnson and Johnson Covid Vaccine
Common drugs associated with Acute myocardial infarction:
All the drugs that are associated with Acute myocardial infarction:
- Acute myocardial infarction (2,063 drugs)
Common conditions associated with Acute myocardial infarction:
All the conditions that are associated with Acute myocardial infarction:
- Acute myocardial infarction (1,439 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atenolol and Bisacodyl drug interaction - now
- Coronary Heart Disease and Fainting - 6 seconds ago
- Tafinlar and Mektovi drug interaction - 8 seconds ago
- Cilostazol and Valacyclovir Hydrochloride drug interaction - 12 seconds ago
- Sumatriptan and Acetylsalicylic Acid drug interaction - 20 seconds ago
- Pseudoephedrine Hydrochloride and Live Birth - 21 seconds ago
- Alendronate Sodium and Swallowing Difficulty - 25 seconds ago
- Incivek and Haldol drug interaction - 26 seconds ago
- Questran Light and Cellulitis - 30 seconds ago
- Lopressor and Bronchitis Fungal - 38 seconds ago